Publication
Observational study on quality of life, safety, and effectiveness of first‐line cetuximab plus chemotherapy in
KRAS
wild‐type metastatic colorectal cancer patients: the ObservEr Study
Carmine Pinto, Francesca Di Fabio, Gerardo Rosati, Ivan R. Lolli, Enzo M. Ruggeri, Libero Ciuffreda, Daris Ferrari, Giovanni Lo Re, Giovanni Rosti, Paolo Tralongo, Raimondo Ferrara, Oscar Alabiso, Silvana Chiara, Giovanni P. Ianniello, Antonio Frassoldati, Domenico Bilancia, Giovanna A. Campanella, Carlo Signorelli, Patrizia Racca, Elena Benincasa, Maria Elena Stroppolo, Francesco Di Costanzo
Cancer Medicine, October 2016, Wiley
DOI: 10.1002/cam4.888